Wiley Alexander Schell

Associate Professor in Medicine
Campus mail 303 Research Dr., Room 337 Sands Bldg., Durham, NC 27710
Phone (919) 684-2523
Email address wiley.schell@duke.edu

Education and Training

  • M.S., University of North Carolina at Chapel Hill, 1979
  • B.S., East Carolina University, 1977

Publications

Autmizguine, Julie, P Brian Smith, Kristi Prather, Catherine Bendel, Girija Natarajan, Margarita Bidegain, David A. Kaufman, et al. “Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants..” J Antimicrob Chemother 73, no. 12 (December 1, 2018): 3482–87. https://doi.org/10.1093/jac/dky353.

PMID
30247579
Full Text

Messina, Julia A., Cameron R. Wolfe, Marion Hemmersbach-Miller, Carmelo Milano, Jamie L. Todd, John Reynolds, Barbara D. Alexander, Wiley A. Schell, Christina A. Cuomo, and John R. Perfect. “Genomic characterization of recurrent mold infections in thoracic transplant recipients..” Transpl Infect Dis 20, no. 5 (October 2018). https://doi.org/10.1111/tid.12935.

PMID
29851203
Full Text

Shaw, Karen Joy, Wiley A. Schell, Jonathan Covel, Gisele Duboc, C. Giamberardino, Mili Kapoor, Molly Moloney, et al. “In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus.” Antimicrobial Agents and Chemotherapy 62, no. 8 (August 1, 2018). https://doi.org/10.1128/ACC00523;e00523-18.

Full Text

Shaw, Karen Joy, Wiley A. Schell, Jonathan Covel, Gisele Duboc, C. Giamberardino, Mili Kapoor, Molly Moloney, et al. “In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus..” Antimicrob Agents Chemother 62, no. 8 (August 2018). https://doi.org/10.1128/AAC.00523-18.

PMID
29891599
Full Text

Hussaini, Syed Mohammed Qasim, Deng Madut, Betty C. Tong, Elizabeth N. Pavlisko, Wiley A. Schell, John R. Perfect, and Nathan M. Thielman. “Pulmonary blastomycosis presenting as primary lung cancer..” Bmc Infect Dis 18, no. 1 (July 18, 2018). https://doi.org/10.1186/s12879-018-3244-0.

PMID
30021526
Full Text

Schell, Wiley A., A. M. Jones, Katyna Borroto-Esoda, and Barbara D. Alexander. “Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species..” Antimicrob Agents Chemother 61, no. 11 (November 2017). https://doi.org/10.1128/AAC.01102-17.

PMID
28827419
Full Text

Schell, W. A., A. M. Jones, E. P. Garvey, W. J. Hoekstra, R. J. Schotzinger, and B. D. Alexander. “Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds..” Antimicrob Agents Chemother 61, no. 3 (March 2017). https://doi.org/10.1128/AAC.01817-16.

PMID
27956419
Full Text

Yu, Yuming, Mary J. Sabulski, Wiley A. Schell, Marcos M. Pires, John R. Perfect, and Steven L. Regen. “Simple Strategy for Taming Membrane-Disrupting Antibiotics..” Bioconjug Chem 27, no. 12 (December 21, 2016): 2850–53. https://doi.org/10.1021/acs.bioconjchem.6b00629.

PMID
27801580
Full Text

Bertumen, J Bradford, Wiley A. Schell, Maria Joyce, Christopher Alley, and Christopher W. Woods. “Diagnostic difficulty identifying Apophysomyces trapeziformis septic arthritis in a patient with multiple myeloma..” Jmm Case Rep 3, no. 6 (December 2016). https://doi.org/10.1099/jmmcr.0.005075.

PMID
28348796
Full Text

Pages